Odyssey Health (ODYY) FCF Margin (2014 - 2016)

Odyssey Health (ODYY) posted quarterly FCF Margin of 63.13% for Q3 2016, up 31.13% quarter-over-quarter from 91.66% in Q2 2016.

Odyssey Health (ODYY) FCF Margin (2014 - 2016) Analysis & Trends

Odyssey Health's FCF Margin history runs 3 years deep, the most recent figure standing at 63.13% for Q3 2016.

In Q3 2016, FCF Margin changed N/A year-over-year to 63.13%; the TTM figure through Apr 2017 stood at 594.98% (down 36233.0% YoY), while the FY2016 annual figure was 171.34%, down 24358.0% from the prior year.
FCF Margin for Q3 2016 stood at 63.13%, up from 91.66% in the prior quarter.
The five-year high for FCF Margin was 87.73% in Q4 2014, with the low at 91.66% in Q2 2016.
The 3-year median for FCF Margin is 26.77% (2015), against an average of 3.95%.
Peak annual rise in FCF Margin reached 11843 bps in 2016, while the deepest fall reached 11843 bps in 2016.
Odyssey Health's FCF Margin stood at 87.73% in 2014, then sank by 69 bps to 26.77% in 2015, then sank by 336 bps to 63.13% in 2016.
Business Quant data shows ODYY's FCF Margin at 63.13% in Q3 2016, 91.66% in Q2 2016, and 26.77% in Q2 2015.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	FCF Margin (Qtr)
1	Abbott Laboratories	199.61 Bn	194.01 Bn	7.27 Bn	15.81%
2	Stryker	127.81 Bn	124.34 Bn	4.50 Bn	16.07%
3	Medtronic	119.04 Bn	109.82 Bn	6.41 Bn	21.26%
4	Boston Scientific	73.68 Bn	73.14 Bn	3.85 Bn	23.50%
5	Edwards Lifesciences	51.96 Bn	47.71 Bn	1.35 Bn	33.60%
6	Dexcom	34.36 Bn	32.41 Bn	830.00 Mn	14.10%
7	GE HealthCare Technologies	33.83 Bn	31.72 Bn	2.18 Bn	1.28%
8	Koninklijke Philips	26.36 Bn	23.04 Bn	4.55 Bn	5.32%
9	Steris	23.06 Bn	22.58 Bn	684.20 Mn	18.73%
10	Odyssey Health	1.01 Mn	711,880.61	-	-

Download Data